23andMe In Collaboration With 20 Lung Cancer Advocacy Organizations, Announced A New Study To Help Advance Research In Lung Cancer
23andMe In Collaboration With 20 Lung Cancer Advocacy Organizations, Announced A New Study To Help Advance Research In Lung Cancer
23andMe聯合20個肺癌倡導組織宣佈一項新研究，旨在推進肺癌研究。
The focus of the Lung Cancer Genetics Study is to better understand the genetics of people with lung cancer in order to improve detection, risk reduction, and care. While recent developments in tumor genetic testing and targeted therapies have provided hope and years of survival to many lung cancer patients, lung cancer remains the number one cause of cancer deaths in both men and women in the United States. Yet, much remains unknown about the disease and its causes.
肺癌基因研究的重點是更好地了解肺癌患者的基因，從而提高檢測、降低風險和改善護理。雖然腫瘤基因檢測和靶向治療的最新發展爲許多肺癌患者帶來了希望和多年的生存時間，但肺癌仍然是美國男女最致命的癌症。然而，關於這種疾病及其原因仍有很多未知。